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With great interest, we read the recent article published
by Heringlake et al. [1] assessing whether preoperative
plasma GDF-15 independently predicts postoperative AKI
in patients undergoing elective cardiac surgery. Many fac-
tors in this study were done well. Other than strict inclu-
sion and exclusion criteria of patients, the authors had
also tried to control most of the known risk factors that
can affect AKI. We thank the authors for their endeavor
to validate that preoperative plasma GDF-15 independ-
ently predicts postoperative AKI in patients undergoing
elective cardiac surgery. Nevertheless, other than the limi-
tations described in the discussion, we note that several
important issues of this study were not addressed.
First, preoperative aspirin therapy was not included in the
data analysis. Actually, preoperative aspirin therapy is com-
mon among patients undergoing cardiac surgery for primary
or secondary prevention of myocardial infarction, stroke,
and death. Preoperative aspirin therapy in cardiac surgery
has been associated with decreased overall morbidity, mor-
tality, and cardiac surgery-associated acute kidney injury [2].
Second, patients receiving valvular heart surgery or
coronary artery bypass graft surgery were included in the
study. However, some patients may use contrast agents
before surgeries. The preoperative contrast angiography or
ventriculography is independently associated with increased
risks of postoperative adverse renal events [3]. Therefore,
contrast angiography or ventriculography should be
included in the data analysis.
Third, it was unclear whether serum creatinine levels
applied in the diagnosis of postoperative AKI had been
adjusted based on the perioperative fluid balance. Moore
et al. [4] showed that using Acute Kidney Injury Network
criteria for diagnosis of AKI, if not adjusting serum
creatinine levels for fluid balance, can underestimate the
severity and incidence of AKI and can confuse the associ-
ation of AKI with postoperative adverse outcomes.
Finally, when assessing the association of preoperative
plasma GDF-15 with postoperative AKI in patients under-
going cardiac surgery, the available literature shows that
postoperative complications including anemia, low cardiac
output syndrome, hypoalbuminemia, and sepsis are
independent risk factors of AKI after cardiac surgery [5].
We are concerned that not taking postoperative covariates
into account would have biased the true effect of
preoperative plasma GDF-15 on the occurrence of postop-
erative AKI in this study.
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[1]. The authors raised concerns that our findings might
be confounded by several variables not addressed
specifically in our publication.
We are of course aware that every tool used for pre-
operative risk stratification must have relevant limitations,
especially if aiming for the prediction of a multifactorial
complication like cardiac surgery-associated acute kidney
injury (CSA-AKI). However, we took the greatest care to
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Zhang et al. criticized that preoperative treatment with
aspirin was not included in our analyses. However, the inci-
dence of AKI in patients preoperatively treated with aspirin
was not different (p = 0.720) from the AKI incidence in
patients not being treated with aspirin. Consequently this
variable was not entered into the multivariate analyses.
We are also aware of the association between immedi-
ate preoperative radio contrast medium exposure and
postoperative AKI [6]. To omit this potential confounder
we focused only on elective surgery, and excluded urgent
patients from the analysis; at least in our institution,
elective patients are rarely subjected to an immediate
preoperative contrast agent exposure.
We admit that not taking into account the postopera-
tive fluid balance may have lead to underestimation of
AKI incidence and severity. Several studies, including
that by Moore et al. [4] cited by Zhang et al., have
shown that adjusting creatinine levels to fluid balance
and body weight will increase the probability to detect
clinically significant AKI. However, precise data on fluid
balance were not available for all patients and thus we
could not adjust postoperative creatinine levels accord-
ingly. Nonetheless, the current definitions of AKI [7] do
not urge making such adjustments; and thus our find-
ings are clearly valid according to current AKI criteria
(based on creatinine).
We of course agree with Zhang et al.’s comment “that
not taking postoperative covariates into account would
have biased the true effect of preoperative plasma GDF-15
on the occurrence of postoperative AKI”. However, as
stated in our manuscript [1], a tool for preoperative risk
stratification will hardly be capable to predict the
unpredictable: bleeding anemia (due to poor surgery!),
unexpected low cardiac output syndrome (e.g., due to in-
adequate cardioplegia), postoperative hypoalbuminemia
(due to excessive need for crystalloid fluids), and sepsis.
Taken together the authors’ comments do not alter
our statement that preoperative plasma GDF-15 is an in-
dependent predictor of postoperative AKI in patients
undergoing elective cardiac surgery and improves the
predictive ability of the Cleveland Clinic Acute Renal
Failure score.
Abbreviation
AKI: Acute kidney injury
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